Safety and Pharmacokinetic Comparison of Exforge® and G-0081 in Healthy Male Volunteers

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT01823913

Recruitment Status : Completed

First Posted : April 4, 2013

Last Update Posted : April 11, 2013

Sponsor:

Information provided by (Responsible Party):

Kyungsoo Park, Severance Hospital

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Completed
Actual Primary Completion Date :	August 2012
Actual Study Completion Date :	September 2012

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Kim Y, Son M, Lee D, Roh H, Son H, Chae D, Bahng MY, Park K. Pharmacokinetic comparison of 2 fixed-dose combination tablets of amlodipine and valsartan in healthy male Korean volunteers: a randomized, open-label, 2-period, single-dose, crossover study. Clin Ther. 2013 Jul;35(7):934-40. doi: 10.1016/j.clinthera.2013.05.021.

To Top